Events
ABPI Code training
ABPI Code training delivered by members of the PMCPA Code of Practice Panel is now available to book
Scottish Medicines Consortium online workshops | various dates available
This workshop provides a practical overview of the Scottish Medicines Consortium (SMC) submission process, led by Dr Catriona McMahon, Lead Industry Member for SMC.
ABPI Industry Summit 2026
This event, for ABPI members and invited guests, will assess the way industry builds familiarity and trust, and will ask if we need to challenge ourselves to work differently to achieve radical change for patients.
Global Pharma & Biotech Summit
The Global Pharma and Biotech Summit, organised by the Financial Times, brings together the leaders, investors and policymakers shaping the next phase of life sciences. Hear from 60+ expert speakers from organisations including Novartis, GSK, Novo Nordisk, Takeda, Bayer and the Medicines and Healthcare products Regulatory Agency (MHRA) as they explore geopolitical and economic disruption, AI, regulation, market access and the rise of new pharmaceutical innovation hubs.
SAVE THE DATE - ABPI Scotland Conference
This conference will bring together government, NHS Scotland, industry, academia and patient organisations to explore how we can turn ABPI Scotland’s Blueprint, into practical action.
The full programme, speaker details and registration information will follow in the coming weeks. In the meantime, please hold the date in your diary.
SAVE THE DATE - ABPI Annual Conference 2027
Save the date for the ABPI Annual Conference 2027, the UK pharmaceutical industry's flagship event bringing together senior leaders, policymakers, clinicians and stakeholders from across the life sciences sector. The conference provides a platform for open dialogue on the issues shaping the future of medicines development, access and innovation in the UK.
Full programme details, speakers and session themes will be announced in due course. Check back for updates, or register your interest to be notified as soon as further information is available.